UTMD
UTAH MEDICAL PRODUCTS INC
+0.16 (+0.22%)74.23USD11.3K成交股數236M市值22.1本益比(近四季)6.4股價營收比-14.3%營收年增(近四季)2026-10-22下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 8.5M-14% | 8.7M-10% | 9.0M-1% | 9.8M-2% | 10.0M-4% | 9.7M-14% | 9.2M-26% | 10.0M-20% | 10.4M | 11.3M | 12.3M | 12.5M |
| 營業成本 | 3.8M | 3.4M | – | 4.2M | 4.4M | 4.2M | – | 4.2M | 4.1M | 4.6M | – | 5.1M |
| 毛利 | 4.8M-15% | 5.3M-5% | 5.3M-1% | 5.6M-3% | 5.6M-11% | 5.5M-18% | 5.3M-25% | 5.8M-21% | 6.3M | 6.8M | 7.1M | 7.4M |
| 毛利率 | 55.8% | 60.6% | 58.2% | 57.1% | 56.2% | 57.0% | 58.1% | 58.0% | 60.1% | 59.7% | 57.6% | 58.8% |
| 研發費用 | 154K | 154K | – | 167K | 135K | 154K | – | 172K | 255K | 266K | – | 138K |
| 銷售管理費用 | 2.0M | 2.6M | – | 2.8M | 2.3M | 2.2M | – | 2.3M | 2.6M | 2.6M | – | 3.3M |
| 營業利益 | 2.6M-17% | 2.6M-19% | – | 2.6M-22% | 3.2M-7% | 3.2M-19% | – | 3.3M-16% | 3.4M | 3.9M | – | 4.0M |
| 營業利益率 | 31.1% | 29.4% | – | 26.6% | 32.1% | 32.5% | – | 33.4% | 33.1% | 34.2% | – | 31.7% |
| 稅後淨利 | 2.7M-12% | 2.6M-14% | 2.6M-12% | 2.6M-26% | 3.0M-12% | 3.0M-23% | 2.9M-32% | 3.6M-9% | 3.5M | 4.0M | 4.3M | 3.9M |
| 淨利率 | 31.5% | 29.9% | 28.4% | 26.8% | 30.6% | 31.3% | 31.7% | 35.6% | 33.2% | 34.9% | 34.8% | 31.5% |
| 稀釋 EPS | 0.84-11% | 0.82-11% | 0.80-7% | 0.82-20% | 0.94-4% | 0.92-16% | 0.86-27% | 1.03-5% | 0.98 | 1.09 | 1.18 | 1.08 |
| 稀釋股數 | 3.2M | 3.2M | – | 3.2M | 3.2M | 3.3M | – | 3.5M | 3.5M | 3.6M | – | 3.6M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 87.5M | 87.4M | 85.8M | 84.3M | 82.2M | 83.3M | 83.0M | 88.5M | 89.2M | 93.8M | 92.9M | 88.2M |
| 應收帳款 | 3.6M | 3.6M | 3.5M | 3.7M | 3.6M | 3.9M | 4.1M | 3.7M | 3.7M | 3.6M | 3.4M | 3.5M |
| 存貨 | 9.0M | 8.7M | 7.9M | 8.1M | 8.2M | 8.6M | 8.8M | 9.1M | 9.1M | 9.2M | 9.6M | 9.7M |
| 總資產 | 125M | 124M | 123M | 122M | 121M | 123M | 123M | 130M | 130M | 135M | 135M | 131M |
| 有息負債 | 195K | 210K | 0 | – | – | 269K | 0 | – | – | – | 0 | – |
| 總負債 | 2.5M | 4.0M | 3.3M | 3.7M | 3.3M | 5.5M | 5.1M | 5.5M | 6.0M | 7.7M | 7.1M | 7.5M |
| 股東權益 | 122M | 120M | 119M | 118M | 118M | 117M | 117M | 124M | 124M | 128M | 128M | 124M |
| 負債比 | 2.0% | 3.2% | 2.7% | 3.1% | 2.7% | 4.5% | 4.2% | 4.2% | 4.6% | 5.7% | 5.3% | 5.7% |
| 淨現金(現金 − 有息負債) | 87.3M | 87.2M | 85.8M | – | – | 83.1M | 83.0M | – | – | – | 92.9M | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 3.1M-30% | – | – | – | 4.5M-15% | – | – | – | 5.3M | – | – |
| 資本支出 | – | 130K | – | – | – | 184K | – | – | – | 22K | – | – |
| 自由現金流 | – | 3.0M-30% | – | – | – | 4.3M-19% | – | – | – | 5.3M | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | 128K | – | – | – | 3.2M | – | – | – | 3.0M | – | – |
| 現金股利 | – | 989K | – | – | – | 1.0M | – | – | – | 1.1M | – | – |
| 自由現金流率 | – | 34.2% | – | – | – | 44.1% | – | – | – | 46.3% | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
地區2025 年度 · 54.3M
| Global | 38.5M | 71.0% | -5.8% |
|---|---|---|---|
| Ous | 15.8M | 29.0% | -9.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 38.5M | -5.8% | 11.3M | 29.3% | 3.48 | 14.3M |
| FY2024 | 40.9M | -18.6% | 13.9M | 33.9% | 3.96 | 14.6M |
| FY2023 | 50.2M | -3.9% | 16.6M | 33.1% | 4.57 | 21.6M |
| FY2022 | 52.3M | +6.6% | 16.5M | 31.5% | 4.52 | 20.3M |
| FY2021 | 49.1M | +16.3% | 14.8M | 30.1% | 4.04 | 20.7M |
| FY2020 | 42.2M | -10.1% | 10.8M | 25.6% | 2.94 | 19.3M |
| FY2019 | 46.9M | +11.7% | 14.7M | 31.4% | 3.94 | 16.5M |
| FY2018 | 42.0M | – | 18.6M | 44.2% | 4.95 | 16.4M |